[ Price : $8.95]
Aldeyra Therapeutics resubmits an NDA for reproxalap to treat the signs and symptoms of dry eye disease.[ Price : $8.95]
FDA warns Chinas Zhejiang Huahai Pharmaceutical Co. about CGMP violations in its production of finished drugs.[ Price : $8.95]
The latest semiannual report issued by the HHS Office of Inspector General raises questions about specific FDA accelerated drug ap...[ Price : $8.95]
A ProPublica investigative report details how a secret small group of FDA officials has approved exemptions for products from over...[ Price : $8.95]
FDA warns Irving, TX-based Reset Technology Corp. about Quality System and other violations in its production of two dental device...[ Price : $8.95]
Sarepta Therapeutics halts shipments of its gene therapy Elevidys (delandistrogene moxeparvovec‑rokl) to nonR...[ Price : $8.95]
FDA warns Indias Kenil Private Healthcare about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA approves updated labeling on Pfizers s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) for men with metastati...